drugset / Trial / NCT07668635

Cannabis Effects on Opioid Self-Administration

NCT07668635

Phase 1 Not yet recruiting 30 enrolled Shanna Babalonis, PhD
RandomizedCrossoverTriple-blindBasic science

Summary

The study will enroll participants with opioid use disorder and participants will reside at the University of Kentucky Hospital for this 6-week inpatient trial. During this time, double-blind doses of cannabis and opioids will be administered. The goal of the project is to determine if cannabis can alter the drive/desire to take opioids.

Timeline

Start
2026-07-30
Primary completion
2030-07-30
Completion
2031-07-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Cannabis Traditional medicine (herbal / TCM)